Clinical Trial: Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07422285) titled 'Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose' on Feb. 12.

Brief Summary: The main objective of this trial is to evaluate the pharmacokinetics of two evolocumab drug products in healthy participants.

Study Start Date: Jan. 16

Study Type: INTERVENTIONAL

Condition: Healthy Participants Pharmacokinetics

Intervention: DRUG: Evolocumab Drug Substance A

Evolocumab drug substance A will be administered SC.

DRUG: Evolocumab Drug Substance B

Evolocumab drug substance B will be administered SC.

Recruitment Status: RECRUITING

Sponsor: Amgen

Disclaimer: Cur...